Bodger, Keith - In: PharmacoEconomics 20 (2002) 10, pp. 639-652
Crohn's disease is a chronic inflammatory bowel disease of unknown aetiology which affects around 35 000 people in the … of severely affected individuals. Indirect costs associated with reduced productivity in Crohn's disease can be high … expectancy is relatively normal. A variety of drugs are employed for the treatment of Crohn's disease, both in an attempt to …